Invivoscribe® is a worldwide leader in precision diagnostics with focus on hematology-oncology and companion diagnostics. We provide ISO 13485 compliant biomarker development, cGMP manufacturing, regulatory expertise, global commercialization, clinical trial services, and internationally standardized testing through an ISO 15189 laboratory network (US, Europe, Asia). Our offerings include NGS gene panels, FLT3 mutation assays, B- and T-cell clonality and MRD testing by NGS and flow cytometry.